Summary
Natera, Inc (Natera), formerly Gene Security Network, Inc is a biotechnology company that develops bioinformatics technologies to check small quantities of genetic material. The company’s products include panorama prenatal testing, miscarriage testing, pre-implantation genetic testing, genetic carrier screening and paternity testing. Its pre-implantation genetic testing includes aneuploidy screening, translocation testing and single gene testing. Natera is used for the treatment of cystic fibrosis, fragile X syndrome, spinal muscular atrophy, bloom syndrome, canavan disease, Niemann-pick disease Type A and familial dysautonomia among others. Natera is headquartered in San Carlos, California, the US.
Natera, Inc. (NTRA) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
'
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Natera, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Natera, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
Natera, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Natera, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 9
Natera, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Natera, Inc., Medical Equipment, Deal Details 12
Venture Financing 12
Natera Raises USD55.5 Million in Venture Financing 12
Natera Raises US$54.6 Million In Venture Financing 14
Gene Security Network Secures US$20 Million In Series D Financing 16
Gene Security Network Secures US$12 Million In Series C Financing Round 18
Partnerships 20
Natera Enters into Agreement with LifeLabs for Non-Invasive Prenatal Test 20
Diagcor Enters Into Agreement With Natera To Market Panorama NIPT In Hong Kong 21
Natera And Laboratorio Dr. F Echevarne Analisis Enter Into Agreement To Distribute Panorama 22
ARUP Labs Enters Into Co-Marketing Agreement With Natura For Panorama 23
Bio-Reference Labs Enters Into Co-Marketing Agreement With Natera For NIPD Test 24
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 25
MedGenome Enters into Licensing Agreement with Natera for NIPT 26
Equity Offering 27
Natera Prices IPO for USD180 Million 27
Natera, Inc. - Key Competitors 29
Key Employees 30
Locations And Subsidiaries 31
Head Office 31
Recent Developments 32
Financial Announcements 32
Mar 08, 2016: Natera Reports Fourth Quarter and Fiscal Year 2015 Financial Results 32
Nov 12, 2015: Natera Reports Third Quarter 2015 Financial Results 34
Aug 12, 2015: Natera Reports Second Quarter 2015 Financial Results 36
Corporate Communications 38
Dec 04, 2015: Natera Announces the Appointment of Michael C. Little as Senior Vice President, R&D 38
Nov 19, 2015: Natera Announces the Appointment of Jimmy Lin as Chief Scientific Officer for Oncology 39
Product News 40
Feb 09, 2016: Genetica Now Offering PanoramaTM NIPT in Switzerland via Natera's Constellation Software Platform 40
Jan 12, 2016: Large-Scale Clinical Study Shows Panorama Prenatal Screen to be Highly Accurate in Identifying 22q11.2 Deletion Syndrome in a General Population 41
Dec 18, 2015: MedGenome Now Offering Panorama NIPT in India via Natera's Constellation Cloud-based Software Platform 42
Apr 15, 2015: Study Published in the Journal Science Identifies the First Genetic Variant Directly Correlated to Mitotic-Origin Aneuploidy in Human Embryos 43
Jan 27, 2015: Natera Adopts the DNAnexus Cloud Genomics Platform to Support a Portfolio of Next-Generation Genetic Tests 44
Other Significant Developments 45
Sep 29, 2015: Natera Bolsters Broadband Service to More Efficiently Deliver its Non-invasive Genetic Screening Technology Services 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46
List of Tables
Natera, Inc., Medical Equipment, Key Facts, 2014 1
Natera, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 1
Natera, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Natera, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 7
Natera, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Natera, Inc., Deals By Market, 2010 to YTD 2016 9
Natera, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 10
Natera Raises USD55.5 Million in Venture Financing 12
Natera Raises US$54.6 Million In Venture Financing 14
Gene Security Network Secures US$20 Million In Series D Financing 16
Gene Security Network Secures US$12 Million In Series C Financing Round 18
Natera Enters into Agreement with LifeLabs for Non-Invasive Prenatal Test 20
Diagcor Enters Into Agreement With Natera To Market Panorama NIPT In Hong Kong 21
Natera And Laboratorio Dr. F Echevarne Analisis Enter Into Agreement To Distribute Panorama 22
ARUP Labs Enters Into Co-Marketing Agreement With Natura For Panorama 23
Bio-Reference Labs Enters Into Co-Marketing Agreement With Natera For NIPD Test 24
Quest Diagnostics Enters Into Agreement With Natera To Offer Panorama, Non-Invasive Prenatal Screening Test 25
MedGenome Enters into Licensing Agreement with Natera for NIPT 26
Natera Prices IPO for USD180 Million 27
Natera, Inc., Key Competitors 29
Natera, Inc., Key Employees 30
List of Figures
Natera, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 1
Natera, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 1
Natera, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 1
Natera, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 1
Natera, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 6
Natera, Inc., Medical Equipment, Deals by Type, 2010 to YTD 2016 7
Natera, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 8
Natera, Inc., Medical Equipment, Deals by Market, 2010 to YTD 2016 9
